Jose A. Fontenla

Profesor Titular de Universidad

Universidade de Santiago de Compostela

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jose A. Fontenla is a Profesor Titular de Universidad at Universidad de Santiago de Compostela, Spain. His research focuses on neuroprotection, pharmacological evaluation of iridoid compounds, and the development of novel agents for the treatment of Parkinson's disease. Recent articles highlight his work on the neuroprotective effects of Achyrocline satureioides and the pharmacological properties of gamma-decanolactone using in vitro and in vivo models.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Year:

SPAIN

View details

Pedro Besada

Profesor Titular de Universidad

Universidade de Vigo

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jose A. Fontenla

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Achyrocline satureioides: in silico and in vivo evaluation of the potential neuroprotective effect of the aqueous extract

In Silico and In Vivo Pharmacological Evaluation of Iridoid Compounds: Geniposide and Asperuloside Profile Study Through Molecular Docking Assay and in the Caenorhabditis elegans Model

Gamma‐Decanolactone Increases Stress Resistance and Improves Toxicity Parameters on the Caenorhabditis elegans Alternative Model

Toxicological assessment of the Achyrocline satureioides aqueous extract in the Caenorhabditis elegans alternative model

8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies

Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug

Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy.

Discovery and optimization of 3-thiophenylcoumarins as novel agents against Parkinson's disease: Synthesis, in vitro and in vivo studies

Gamma-decanolactone attenuates acute and chronic seizures in mice: A possible role of adenosine A<inf>1</inf>receptors

Gamma-decanolactone attenuates acute and chronic seizures in mice: a possible role of adenosine A1 receptors.

Collaborators (6)

María Isabel Loza García

Carmen Terán

Dolores Viña

Maria João Matos

Jose Brea

Pedro Besada

Make your next move.